Conversion surgery for microsatellite instability-high gastric cancer with a complete pathological response to pembrolizumab: a case report

Conversion surgery for microsatellite instability-high gastric cancer with a complete pathological response to pembrolizumab: a case report

Abstract Background Immune checkpoint inhibitors are reportedly effective in treating microsatellite instability (MSI)-high gastric cancer. There are a few case reports of conversion surgery (CS) with nivolumab but none with pembrolizumab. Herein, we describe a patient with MSI-high gastric cancer w...

Full description

Bibliographic Details
Main Authors: Yoshifumi Hidaka, Takaaki Arigami, Yusaku Osako, Ryosuke Desaki, Masahiro Hamanoue, Sonshin Takao, Mari Kirishima, Takao Ohtsuka
Format: Article
Language:English
Published: BMC 2022-06-01
Series:World Journal of Surgical Oncology
Subjects:
Unresectable gastric cancer
MSI-high
Pembrolizumab
Conversion surgery
R0 resection
Online Access:https://doi.org/10.1186/s12957-022-02661-8

Internet

https://doi.org/10.1186/s12957-022-02661-8

Similar Items